Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer. - Wikidata - awgldk - TriplyDB

Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer.

Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer.

http://www.wikidata.org/entity/Q38991031

about

Diversin is overexpressed in breast cancer and accelerates cell proliferation and invasion Serum thymidine kinase 1 activity in solid tumor (breast and colorectal cancer) patients treated with adjuvant chemotherapy.CXCL12 chemokine expression suppresses human breast cancer growth and metastasis in vitro and in vivo NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma Cytosolic TMEM88 promotes triple-negative breast cancer by interacting with Dvl.A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease.Elevated preoperative serum cancer antigen 15.3 levels are associated with reduced disease-free survival: a single-institution experience.Overexpression of SMARCA5 correlates with cell proliferation and migration in breast cancer.CARMA3 overexpression accelerates cell proliferation and inhibits paclitaxel-induced apoptosis through NF-κB regulation in breast cancer cells.Overexpression of CRKL correlates with malignant cell proliferation in breast cancer.Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients.TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-κB pathway.

P2860

Q33654904-757D1AE9-06BA-4B54-B4D3-665EB1CE1860 Q34345493-FE65D415-BC6F-4F4A-B775-7BEE718EB026 Q34501602-D771A70D-5D62-436C-871B-84154610198C Q35741119-D25E268A-8039-412D-BCB1-1DCE8E59F94D Q36413113-A5E54D4A-DBE6-4E0B-A47F-C5BE1FFEA716 Q37366227-0FC3B420-4EA3-4298-BA65-C72C419E86EE Q37593523-28D83E9E-0C01-4DD5-909B-581C58F3F588 Q38942137-60D8B1BA-9E90-46F9-9611-FD329BED3505 Q39147186-503AE21E-6943-42EF-AEE4-83877449A443 Q39149858-1359636A-4A23-42BE-B3D7-1946FE950AE1 Q55036428-4E39BB2A-E5D4-4B9E-B98A-C21C9177D73D Q55245541-02CBBA1C-A64C-4208-826C-72C5BEB59864

P2860

Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer.

http://www.wikidata.org/entity/Q38991031

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer.

@en

type

label

Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer.

@en

prefLabel

Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer.

@en

P1433

Q38991031-A4457A82-E395-40F1-B65E-C211974CEEB3

P1476

Q38991031-4D6E55B6-069E-432F-A502-67208878F675

P2093

Q38991031-05D6529B-E152-4C12-A6BE-170102FA4D4F

Q38991031-2E198666-4A6F-4F19-B1A3-88A0720218DE

Q38991031-457DE3AA-5377-425E-9C26-4398211BE01F

Q38991031-506B1793-8B4C-499F-9946-B0D45442149D

Q38991031-66BE016C-5E7F-4D18-AB1F-947114495649

Q38991031-90B00684-3CEA-4060-8D44-F818CE53CCD8

P2860

Q38991031-00EDF312-DDBD-427E-9051-90C9E93D6BEA

Q38991031-00F43882-D736-452A-8D56-DA04666F45AA

Q38991031-01CA0CAD-4D22-4FEC-B2DE-BE7A11CABDB0

Q38991031-2B61DE9E-0F8A-48FC-94E4-532F4C2AA0C5

Q38991031-36E85B9A-D6DD-4762-9AEA-38FD530EEE9E

Q38991031-53DF9CA3-38C1-4E8B-8ECF-B637C52FB421

Q38991031-5D6E262C-A13B-4AF3-B72E-3D38E97B220B

Q38991031-62DBC694-A792-48B7-92FB-E037E0BE5B7D

Q38991031-6752B4DE-86A5-4FB9-B906-88C3147966E7

Q38991031-89BD018D-31B9-4D9D-8229-CF63B3033E33

P2888

Q38991031-1C1FC96E-DA2D-449B-964E-3EE64F9E4ECE

P304

Q38991031-A9D10F8E-E34C-40BD-BA6F-B2F701DFE3A7

P31

Q38991031-5A35B0C5-6580-4759-AEA5-2C2B90A472D7

P356

Q38991031-D8C2C006-CDD7-4EB3-AEED-058F0C498D71

P433

Q38991031-D711383C-9FFB-4415-AF62-4A74894A32DD

P478

Q38991031-E08FE2FF-97A1-4FCB-9DDF-7CC009968212

P577

Q38991031-58023F91-3DE9-47DE-A459-1B5F8B8846DE

P6179

Q38991031-120DADA5-5C86-4EBE-8866-677478A592F7

P698

Q38991031-9EB8153D-83FB-4790-808C-18EE62D41AF8

P921

Q38991031-31F96CBA-B916-42B3-85B0-26C2D5992C09

P356

S13277-012-0500-6

P1433

P1476

Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer.

@en

P2093

Abdelbaset Buhmeida

http://www.w3.org/2001/XMLSchema#string

Asma Gliwan

http://www.w3.org/2001/XMLSchema#string

Fathi Abdalla

http://www.w3.org/2001/XMLSchema#string

Jamela Boder

http://www.w3.org/2001/XMLSchema#string

Mohamed Elfagieh

http://www.w3.org/2001/XMLSchema#string

Wafa Nichols

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

HER2. a 'predictive factor' ready to use in the daily management of breast cancer patients?

Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving "metronomic" zoledronic acid.

Can thymidine kinase levels in breast tumors predict disease recurrence?

High preoperative CA 15-3 concentrations predict adverse outcome in node-negative and node-positive breast cancer: study of 600 patients with histologically confirmed breast cancer.

Mechanical Diagnosis and Therapy approach to assessment and treatment of derangement of the sacro-iliac joint.

Assessing TP53 status in human tumours to evaluate clinical outcome.

Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes.

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.

P2888

s13277-012-0500-6

P304

2371-2377

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-012-0500-6

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1016505717

http://www.w3.org/2001/XMLSchema#string

P698

22948780

http://www.w3.org/2001/XMLSchema#string

P921